Dawson James downgraded Sorrento Therapeutics to Neutral from Buy.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SRNE:
- Joint Statement by Sorrento Therapeutics, Inc. and Scilex Holding Company on Today’s Isolated Chapter 11 Filing By Sorrento Therapeutics, Inc.
- Sorrento Therapeutics files for Chapter 11 bankruptcy in Texas
- Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., acquires rights to FDA-Approved ELYXYB™ in the U.S. and Canada for the acute treatment of migraine
- Scilex acquires rights to FDA-approved ELYXYB in U.S., Canada
- Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Record and Meeting Dates for its first Annual Meeting of Stockholders